This review synthesizes current knowledge on the implications and consequences of glycosylation in AD and other tauopathies, with focus on tau biology, amyloid processing, immune and synaptic modulation, and translational potential for biomarker discovery and therapy. Here, MAPT is linked to tauopathy.